vs

Side-by-side financial comparison of Webull Corp (BULL) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Webull Corp is the larger business by last-quarter revenue ($131.5M vs $74.7M, roughly 1.8× Health Catalyst, Inc.). Webull Corp runs the higher net margin — -21.5% vs -121.9%, a 100.4% gap on every dollar of revenue. On growth, Webull Corp posted the faster year-over-year revenue change (46.3% vs -6.2%). Webull Corp produced more free cash flow last quarter ($271.7M vs $9.6M).

Webull Corporation, often stylized as simply Webull, is a US-based financial services holding company headquartered in St. Petersburg, Florida. It provides an electronic trading platform of the same name.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

BULL vs HCAT — Head-to-Head

Bigger by revenue
BULL
BULL
1.8× larger
BULL
$131.5M
$74.7M
HCAT
Growing faster (revenue YoY)
BULL
BULL
+52.5% gap
BULL
46.3%
-6.2%
HCAT
Higher net margin
BULL
BULL
100.4% more per $
BULL
-21.5%
-121.9%
HCAT
More free cash flow
BULL
BULL
$262.0M more FCF
BULL
$271.7M
$9.6M
HCAT

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BULL
BULL
HCAT
HCAT
Revenue
$131.5M
$74.7M
Net Profit
$-28.3M
$-91.0M
Gross Margin
Operating Margin
-16.3%
-115.3%
Net Margin
-21.5%
-121.9%
Revenue YoY
46.3%
-6.2%
Net Profit YoY
-144.3%
-340.3%
EPS (diluted)
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BULL
BULL
HCAT
HCAT
Q4 25
$74.7M
Q3 25
$76.3M
Q2 25
$131.5M
$80.7M
Q1 25
$79.4M
Q4 24
$79.6M
Q3 24
$76.4M
Q2 24
$89.9M
$75.9M
Q1 24
$74.7M
Net Profit
BULL
BULL
HCAT
HCAT
Q4 25
$-91.0M
Q3 25
$-22.2M
Q2 25
$-28.3M
$-41.0M
Q1 25
$-23.7M
Q4 24
$-20.7M
Q3 24
$-14.7M
Q2 24
$-11.6M
$-13.5M
Q1 24
$-20.6M
Gross Margin
BULL
BULL
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
BULL
BULL
HCAT
HCAT
Q4 25
-115.3%
Q3 25
-22.9%
Q2 25
-16.3%
-46.0%
Q1 25
-25.4%
Q4 24
-22.0%
Q3 24
-17.9%
Q2 24
-11.4%
-20.8%
Q1 24
-30.5%
Net Margin
BULL
BULL
HCAT
HCAT
Q4 25
-121.9%
Q3 25
-29.1%
Q2 25
-21.5%
-50.8%
Q1 25
-29.9%
Q4 24
-26.0%
Q3 24
-19.3%
Q2 24
-12.9%
-17.8%
Q1 24
-27.6%
EPS (diluted)
BULL
BULL
HCAT
HCAT
Q4 25
$-1.29
Q3 25
$-0.32
Q2 25
$-0.59
Q1 25
$-0.35
Q4 24
$-0.33
Q3 24
$-0.24
Q2 24
$-0.23
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BULL
BULL
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$476.7M
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$751.6M
$245.8M
Total Assets
$2.6B
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BULL
BULL
HCAT
HCAT
Q4 25
$95.7M
Q3 25
$91.5M
Q2 25
$476.7M
$97.3M
Q1 25
$342.0M
Q4 24
$392.0M
Q3 24
$387.3M
Q2 24
$308.3M
Q1 24
$327.8M
Total Debt
BULL
BULL
HCAT
HCAT
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
BULL
BULL
HCAT
HCAT
Q4 25
$245.8M
Q3 25
$331.9M
Q2 25
$751.6M
$347.5M
Q1 25
$376.8M
Q4 24
$365.2M
Q3 24
$355.0M
Q2 24
$-2.9B
$357.0M
Q1 24
$357.2M
Total Assets
BULL
BULL
HCAT
HCAT
Q4 25
$502.6M
Q3 25
$587.1M
Q2 25
$2.6B
$616.2M
Q1 25
$891.5M
Q4 24
$858.9M
Q3 24
$813.0M
Q2 24
$691.7M
Q1 24
$695.1M
Debt / Equity
BULL
BULL
HCAT
HCAT
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BULL
BULL
HCAT
HCAT
Operating Cash FlowLast quarter
$272.1M
$9.9M
Free Cash FlowOCF − Capex
$271.7M
$9.6M
FCF MarginFCF / Revenue
206.6%
12.9%
Capex IntensityCapex / Revenue
0.3%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BULL
BULL
HCAT
HCAT
Q4 25
$9.9M
Q3 25
$-464.0K
Q2 25
$272.1M
$-9.0M
Q1 25
$280.0K
Q4 24
$-3.5M
Q3 24
$6.2M
Q2 24
$1.6M
Q1 24
$10.3M
Free Cash Flow
BULL
BULL
HCAT
HCAT
Q4 25
$9.6M
Q3 25
$-719.0K
Q2 25
$271.7M
$-9.2M
Q1 25
$-390.0K
Q4 24
$-3.9M
Q3 24
$5.5M
Q2 24
$1.3M
Q1 24
$10.1M
FCF Margin
BULL
BULL
HCAT
HCAT
Q4 25
12.9%
Q3 25
-0.9%
Q2 25
206.6%
-11.4%
Q1 25
-0.5%
Q4 24
-4.9%
Q3 24
7.2%
Q2 24
1.7%
Q1 24
13.5%
Capex Intensity
BULL
BULL
HCAT
HCAT
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
0.3%
Q1 25
0.8%
Q4 24
0.5%
Q3 24
0.9%
Q2 24
0.4%
Q1 24
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BULL
BULL

Segment breakdown not available.

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons